Tersera Therapeutics
ZOLADEX
Manufacturer:
Tersera Therapeutics
Name:
ZOLADEX
HCPCS Code Descriptor:
Goserelin acetate implant, per 3.6 mg
Category:
J Code
HCPCS:
J9202
NDC(s):
70720-0950-36, 70720-0951-30
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
ZOLADEX is an Oncology drug manufactured by Tersera Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9202 is aligned to the drug ZOLADEX.